Drug Side Effects
Search
GESTATIONAL TROPHOBLASTIC TUMOUR
GESTATIONAL TROPHOBLASTIC TUMOUR
was reported 47 times
GESTATIONAL TROPHOBLASTIC TUMOUR is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Actinomycin [EPC]
2
0.0009
1
Progestin Antagonist [EPC]
1
0.0002
2
Topoisomerase Inhibitor [EPC]
12
0.0002
3
Prostaglandin E1 Analog [EPC]
2
0.0001
4
Alkylating Drug [EPC]
10
0.0000
5
Platinum-based Drug [EPC]
9
0.0000
6
Folate Analog Metabolic Inhibitor [EPC]
14
0.0000
7
Copper-containing Intrauterine Device [EPC]
1
0.0000
8
Macrolide Antimicrobial [EPC]
1
0.0000
9
CD20-directed Cytolytic Antibody [EPC]
5
0.0000
10
Microtubule Inhibitor [EPC]
2
0.0000
11
Integrin Receptor Antagonist [EPC]
1
0.0000
12
Purine Antimetabolite [EPC]
1
0.0000
13
Interleukin-12 Antagonist [EPC]
1
0.0000
14
Interleukin-23 Antagonist [EPC]
1
0.0000
15
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
16
Estrogen [EPC]
1
0.0000
17
Tumor Necrosis Factor Blocker [EPC]
5
0.0000
18
Mood Stabilizer [EPC]
1
0.0000
19
Anti-epileptic Agent [EPC]
1
0.0000
20
Retinoid [EPC]
1
0.0000
21
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
22
Progestin [EPC]
1
0.0000
23
Benzodiazepine [EPC]
1
0.0000
24
Corticosteroid [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000